[Congressional Record Volume 167, Number 71 (Monday, April 26, 2021)]
[Daily Digest]
[Page D424]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]





                            NEW PUBLIC LAWS

      (For last listing of Public Laws, see Daily Digest, p. D359)
  S. 164, to educate health care providers and the public on biosimilar 
biological products. Signed on April 23, 2021. (Public Law 117-8)
  S. 415, to amend the Federal Food, Drug, and Cosmetic Act with 
respect to the scope of new chemical exclusivity. Signed on April 23, 
2021. (Public Law 117-9)
  S. 422, to allow Senators, Senators-elect, committees of the Senate, 
leadership offices, and other offices of the Senate to share employees. 
Signed on April 23, 2021. (Public Law 117-10)
  S. 578, to improve the health and safety of Americans living with 
food allergies and related disorders, including potentially life-
threatening anaphylaxis, food protein-induced enterocolitis syndrome, 
and eosinophilic gastrointestinal diseases. Signed on April 23, 2021. 
(Public Law 117-11)